see more

  • Day one: First Townhall meeting RegMed XB successful!

    Day one: First Townhall meeting RegMed XB successful!

    18 Mar 2021
  • Next building block for cartilage production

    Next building block for cartilage production

    03 Feb 2021
  • Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success

    Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success

    14 Jan 2021
  • First investment in potential medicine for stroke by FIRST-fund

    First investment in potential medicine for stroke by FIRST-fund

    11 Dec 2020
  • The Ethics of Synthetic Embryology: A Blessing or a Curse?

    The Ethics of Synthetic Embryology: A Blessing or a Curse?

    02 Dec 2020
  • One step closer to therapies based on cartilage regeneration

    One step closer to therapies based on cartilage regeneration

    18 Nov 2020
  • “Renal replacement therapy in Regenerative Medicine”

    “Renal replacement therapy in Regenerative Medicine”

    11 Nov 2020
  • RegMed XB column in the Dutch patient magazine “Wisselwerking”

    RegMed XB column in the Dutch patient magazine “Wisselwerking”

    30 Oct 2020
  • An ex vivo human osteochondral culture model

    An ex vivo human osteochondral culture model

    07 Oct 2020
  • More advances in research on kidney organoids

    More advances in research on kidney organoids

    21 Jul 2020
  • High potential of renal organoids and tubuloids in the treatment of kidney diseases

    High potential of renal organoids and tubuloids in the treatment of kidney diseases

    20 Jul 2020
  • Great step forward in the Dutch regenerative medicine field

    Great step forward in the Dutch regenerative medicine field

    12 Jun 2020

    Have something to share?

    Now you can contribute to keep our news section fresh and up-to date with relevant events and grants, research results and high impact publications related to REGMED XB’ Moonshots. Contributions can be sent to This email address is being protected from spambots. You need JavaScript enabled to view it.. Please submit the text in English and include a short title. We are looking forward to your input!

    • Diabetes FondsDiabetes Fonds
    • Leids Universitair Medisch CentrumLeids Universitair Medisch Centrum
    • Provincie UtrechtProvincie Utrecht
    • RijksoverheidRijksoverheid
    • Health HollandHealth Holland
    • Maastricht UMC+Maastricht UMC+
    • Provincie LimburgProvincie Limburg
    • TU/eTU/e
    • NierstichtingNierstichting
    • Provincie Noord-BrabantProvincie Noord-Brabant
    • Universiteit LeidenUniversiteit Leiden
    • LeidenLeiden
    • Stichting DONStichting DON
    • ReumaNederlandReumaNederland
    • Maastricht UniversityMaastricht University
    • UMC UtrechtUMC Utrecht
    • Utrecht UniversityUtrecht University
    • KU LeuvenKU Leuven
    • VIBVIB
    • HartstichtingHartstichting
    • 300Microns300Microns
    • Access2boneAccess2bone
    • Chemelot InSciTeChemelot InSciTe
    • Cyto smartCyto smart
    • Dutch CardioVascular AllianceDutch CardioVascular Alliance
    • Flanders State of the ArtFlanders State of the Art
    • FUJIFILMFUJIFILM
    • GalápagosGalápagos
    • HCM MedicalHCM Medical
    • Kuros BiosciencesKuros Biosciences
    • LifeTec GroupLifeTec Group
    • MateriomicsMateriomics
    • MimetasMimetas
    • Ministerie van Economische Zaken en KlimaatMinisterie van Economische Zaken en Klimaat
    • Ministerie van Onderwijs Cultuur en WetenschapMinisterie van Onderwijs Cultuur en Wetenschap
    • Ministerie van Volksgezondheid, Welzijn en SportMinisterie van Volksgezondheid, Welzijn en Sport
    • NcardiaNcardia
    • Nestegg BiotechNestegg Biotech
    • NTrans TechnologiesNTrans Technologies
    • Ostheo PharmaOstheo Pharma
    • Provincie Zuid-HollandProvincie Zuid-Holland
    • ScinusScinus
    • Starfish InnovationsStarfish Innovations
    • StentitStentit
    • SupraPolixSupraPolix
    • veldlaserveldlaser
    • VisualsonicsVisualsonics
    • XeltisXeltis

    Information for

    Contact information

    • Stichting REGMED XB
    • Minderbroedersberg 4-6, 6211 LK  Maastricht
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    Connect with us

    Copyright © 2021 RegMed XB. All rights reserved
    Realisation & design by Joomlapartner